Treponema Pallidum Tests Market : TOC


  • Published On : Jan-2019 |
  • Pages : 103 Pages |
  • Format :

Table of Content

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Taxonomy
   2.2. Market Definition

3. Treponema Pallidum Tests Market Opportunity Analysis
   3.1. Macro-Economic Factors
   3.2. Opportunity Analysis

4. Market Background
   4.1. Market Dynamics
        4.1.1. Drivers
        4.1.2. Restraints
        4.1.3. Trends

5. Key Inclusions
   5.1. Pricing Analysis

6. North America Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026
   6.1. Introduction
   6.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2013–2017
        6.2.1. U.S.
        6.2.2. Canada
   6.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
   6.4. Historical Market Value (US$ Mn) Trend Analysis by Test Type, 2013–2017
        6.4.1. Treponemal test
               6.4.1.1. Treponema Pallidum Particle Agglutination Assay (TP-PA) Test
               6.4.1.2. Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test
               6.4.1.3. Treponema Pallidum Hemagglutination Assay (TPHA)
               6.4.1.4. Others
        6.4.2. Non-treponemal tests
               6.4.2.1. Venereal Disease Research Laboratory (VDRL) Test
               6.4.2.2. Rapid Plasma Reagin (RPR) Test
               6.4.2.3. Toluidine Red Unheated Serum Test (TRUST)
   6.5. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
   6.6. Historical Market Value (US$ Mn) Trend Analysis by Service Provider, 2013–2017
        6.6.1. Hospitals
        6.6.2. Specialty Clinics
        6.6.3. Ambulatory Surgical Centers
        6.6.4. Diagnostic Laboratories
        6.6.5. Academic & Research Institutes
   6.7. Market Size (US$ Mn) Forecast By Service Provider, 2018–2026
   6.8. Market Attractiveness Analysis
        6.8.1. By Country
        6.8.2. By Test Type
        6.8.3. By Service provider

7. Latin America Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026
   7.1. Introduction
   7.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2013–2017
        7.2.1. Brazil
        7.2.2. Mexico
        7.2.3. Rest of Latin America
   7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
   7.4. Historical Market Value (US$ Mn) Trend Analysis by Test Type, 2013–2017
        7.4.1. Treponemal test
               7.4.1.1. Treponema Pallidum Particle Agglutination Assay (TP-PA) Test
               7.4.1.2. Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test
               7.4.1.3. Treponema Pallidum Hemagglutination Assay (TPHA)
               7.4.1.4. Others
        7.4.2. Non-treponemal tests
               7.4.2.1. Venereal Disease Research Laboratory (VDRL) Test
               7.4.2.2. Rapid Plasma Reagin (RPR) Test
               7.4.2.3. Toluidine Red Unheated Serum Test (TRUST)
   7.5. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
   7.6. Historical Market Value (US$ Mn) Trend Analysis by Service Provider, 2013–2017
        7.6.1. Hospitals
        7.6.2. Specialty Clinics
        7.6.3. Ambulatory Surgical Centers
        7.6.4. Diagnostic Laboratories
        7.6.5. Academic & Research Institutes
   7.7. Market Size (US$ Mn) Forecast By Service Provider, 2018–2026
   7.8. Market Attractiveness Analysis
        7.8.1. By Country
        7.8.2. By Test Type
        7.8.3. By Service provider

8. Europe Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026
   8.1. Introduction
   8.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2013–2017
        8.2.1. Germany
        8.2.2. U.K.
        8.2.3. France
        8.2.4. Italy
        8.2.5. Spain
        8.2.6. Rest of Europe
   8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
   8.4. Historical Market Value (US$ Mn) Trend Analysis by Test Type, 2013–2017
        8.4.1. Treponemal test
               8.4.1.1. Treponema Pallidum Particle Agglutination Assay (TP-PA) Test
               8.4.1.2. Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test
               8.4.1.3. Treponema Pallidum Hemagglutination Assay (TPHA)
               8.4.1.4. Others
        8.4.2. Non-treponemal tests
               8.4.2.1. Venereal Disease Research Laboratory (VDRL) Test
               8.4.2.2. Rapid Plasma Reagin (RPR) Test
               8.4.2.3. Toluidine Red Unheated Serum Test (TRUST)
   8.5. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
   8.6. Historical Market Value (US$ Mn) Trend Analysis by Service Provider, 2013–2017
        8.6.1. Hospitals
        8.6.2. Specialty Clinics
        8.6.3. Ambulatory Surgical Centers
        8.6.4. Diagnostic Laboratories
        8.6.5. Academic & Research Institutes
   8.7. Market Size (US$ Mn) Forecast By Service Provider, 2018–2026
   8.8. Market Attractiveness Analysis
        8.8.1. By Country
        8.8.2. By Test Type
        8.8.3. By Service provider

9. Asia Pacific Excluding China Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026
   9.1. Introduction
   9.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2013–2017
        9.2.1. Japan
        9.2.2. India
        9.2.3. China
        9.2.4. Australia and New Zealand
        9.2.5. ASEAN
        9.2.6. Rest of Asia Pacific
   9.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
   9.4. Historical Market Value (US$ Mn) Trend Analysis by Test Type, 2013–2017
        9.4.1. Treponemal test
               9.4.1.1. Treponema Pallidum Particle Agglutination Assay (TP-PA) Test
               9.4.1.2. Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test
               9.4.1.3. Treponema Pallidum Hemagglutination Assay (TPHA)
               9.4.1.4. Others
        9.4.2. Non-treponemal tests
               9.4.2.1. Venereal Disease Research Laboratory (VDRL) Test
               9.4.2.2. Rapid Plasma Reagin (RPR) Test
               9.4.2.3. Toluidine Red Unheated Serum Test (TRUST)
   9.5. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
   9.6. Historical Market Value (US$ Mn) Trend Analysis by Service Provider, 2013–2017
        9.6.1. Hospitals
        9.6.2. Specialty Clinics
        9.6.3. Ambulatory Surgical Centers
        9.6.4. Diagnostic Laboratories
        9.6.5. Academic & Research Institutes
   9.7. Market Size (US$ Mn) Forecast By Service Provider, 2018–2026
   9.8. Market Attractiveness Analysis
        9.8.1. By Country
        9.8.2. By Test Type
        9.8.3. By Service provider

10. Middle East & Africa Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026
   10.1. Introduction
   10.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2013–2017
        10.2.1. GCC Countries
        10.2.2. South Africa
        10.2.3. Rest of MEA
   10.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
   10.4. Historical Market Value (US$ Mn) Trend Analysis by Test Type, 2013–2017
        10.4.1. Treponemal test
               10.4.1.1. Treponema Pallidum Particle Agglutination Assay (TP-PA) Test
               10.4.1.2. Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test
               10.4.1.3. Treponema Pallidum Hemagglutination Assay (TPHA)
               10.4.1.4. Others
        10.4.2. Non-treponemal tests
               10.4.2.1. Venereal Disease Research Laboratory (VDRL) Test
               10.4.2.2. Rapid Plasma Reagin (RPR) Test
               10.4.2.3. Toluidine Red Unheated Serum Test (TRUST)
   10.5. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
   10.6. Historical Market Value (US$ Mn) Trend Analysis by Service Provider, 2013–2017
        10.6.1. Hospitals
        10.6.2. Specialty Clinics
        10.6.3. Ambulatory Surgical Centers
        10.6.4. Diagnostic Laboratories
        10.6.5. Academic & Research Institutes
   10.7. Market Size (US$ Mn) Forecast By Service Provider, 2018–2026
   10.8. Market Attractiveness Analysis
        10.8.1. By Country
        10.8.2. By Test Type
        10.8.3. By Service provider

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Global Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026, By Region
   13.1. Introduction/Key Findings
   13.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2013–2017
   13.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
        13.3.1. North America
        13.3.2. Latin America
        13.3.3. Europe
        13.3.4. Asia Pacific
        13.3.5. Middle East & Africa
   13.4. Market Attractiveness Analysis by Region

14. Global Treponema Pallidum Tests Analysis 2013–2017 and Forecast 2018–2026, By Test Type
   14.1. Introduction/Key Findings
   14.2. Historical Market Size (US$ Mn) Trend Analysis by Test Type, 2013–2017
        14.2.1. Treponemal test
               14.2.1.1. Treponema Pallidum Particle Agglutination Assay (TP-PA) Test
               14.2.1.2. Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test
               14.2.1.3. Treponema Pallidum Hemagglutination Assay (TPHA)
               14.2.1.4. Others
        14.2.2. Non-treponemal tests
               14.2.2.1. Venereal Disease Research Laboratory (VDRL) Test
               14.2.2.2. Rapid Plasma Reagin (RPR) Test
               14.2.2.3. Toluidine Red Unheated Serum Test (TRUST
   14.3. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
   14.4. Market Attractiveness Analysis by Test Type

15. Global Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026, By Service Provider
   15.1. Introduction/Key Findings
   15.2. Historical Market Size (US$ Mn) Trend Analysis by Service Provider, 2013–2017
        15.2.1. Hospitals
        15.2.2. Specialty Clinics
        15.2.3. Ambulatory Surgical Centers
        15.2.4. Diagnostic Laboratories
        15.2.5. Academic & Research Institutes
   15.3. Market Size (US$ Mn) Forecast By Service Provider, 2018–2026
   15.4. Market Attractiveness Analysis by Service Provider

16. Global Treponema Pallidum Tests Market Analysis 2013–2017 and Forecast 2018–2026
   16.1. Market Value Share Analysis by All Segment
   16.2. Y-o-Y Growth Analysis by All Segment
   16.3. Absolute $ Opportunity

17. Assumptions and Acronyms Used

18. Research Methodology


List of Tables

Table 01: North America Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 02: North America Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Test Type
Table 03: North America Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Provider
Table 04: Latin America Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 05: Latin America Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Test Type
Table 06: Latin America Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Provider
Table 07: Europe Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 08: Europe Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Test Type
Table 09: Europe Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Provider
Table 10: Asia Pacific Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 11: Asia Pacific Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Test Type
Table 12: Asia Pacific Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Provider
Table 13: Middle East & Africa Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 14: Middle East & Africa Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Test Type
Table 15: Middle East & Africa Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Provider
Table 16: Global Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Region
Table 17: Global Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Test Type
Table 18: Global Treponema Pallidum Tests Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Provider


List of Figures

Figure 01: Treponema Pallidum Tests Market Value Share by Region (2018)
Figure 02: Global Treponema Pallidum Tests Market Share, By Region (2018)
Figure 03: Global Treponema Pallidum Tests Market Share, By Test Type (2018)
Figure 04: Global Treponema Pallidum Tests Market Share, By Service Provider (2018)
Figure 05: North America Treponema Pallidum Tests Market Share, By Country (2018)
Figure 06: North America Treponema Pallidum Tests Market Share, By Test Type (2018)
Figure 07: North America Treponema Pallidum Tests Market Share, By Service Provider (2018)
Figure 08: North America Treponema Pallidum Tests Market Size (US$ Mn) Analysis, 2013–2017
Figure 09: North America Treponema Pallidum Tests Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 10: North America Treponema Pallidum Tests Market Attractiveness Analysis, By Country
Figure 11: North America Treponema Pallidum Tests Market Attractiveness Analysis, By Test Type
Figure 12: North America Treponema Pallidum Tests Market Attractiveness Analysis, By Service Provider
Figure 13: Latin America Treponema Pallidum Tests Market Share, By Country (2018)
Figure 14: Latin America Treponema Pallidum Tests Market Share, By Test Type (2018)
Figure 15: Latin America Treponema Pallidum Tests Market Share, By Service Provider (2018)
Figure 16: Latin America Treponema Pallidum Tests Market Size (US$ Mn) Analysis, 2013–2017
Figure 17: Latin America Treponema Pallidum Tests Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 18: Latin America Treponema Pallidum Tests Market Attractiveness Analysis, By Country
Figure 19: Latin America Treponema Pallidum Tests Market Attractiveness Analysis, By Test Type
Figure 20: Latin America Treponema Pallidum Tests Market Attractiveness Analysis, By Service Provider
Figure 21: Europe Treponema Pallidum Tests Market Share, By Country (2018)
Figure 22: Europe Treponema Pallidum Tests Market Share, By Test Type (2018)
Figure 23: Europe Treponema Pallidum Tests Market Share, By Service Provider (2018)
Figure 24: Europe Treponema Pallidum Tests Market Size (US$ Mn) Analysis, 2013–2017
Figure 25: Europe Treponema Pallidum Tests Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 26: Europe Treponema Pallidum Tests Market Attractiveness Analysis, By Country
Figure 27: Europe Treponema Pallidum Tests Market Attractiveness Analysis, By Test Type
Figure 28: Europe Treponema Pallidum Tests Market Attractiveness Analysis, By Service Provider
Figure 29: Asia Pacific Treponema Pallidum Tests Market Share, By Country (2018)
Figure 30: Asia Pacific Treponema Pallidum Tests Market Share, By Test Type (2018)
Figure 31: Asia Pacific Treponema Pallidum Tests Market Share, By Service Provider (2018)
Figure 32: Asia Pacific Treponema Pallidum Tests Market Size (US$ Mn) Analysis, 2013–2017
Figure 33: Asia Pacific Treponema Pallidum Tests Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 34: Asia Pacific Treponema Pallidum Tests Market Attractiveness Analysis, By Country
Figure 35: Asia Pacific Treponema Pallidum Tests Market Attractiveness Analysis, By Test Type
Figure 36: Asia Pacific Treponema Pallidum Tests Market Attractiveness Analysis, By Service Provider
Figure 37: Middle East & Africa Treponema Pallidum Tests Market Share, By Country (2018)
Figure 38: Middle East & Africa Treponema Pallidum Tests Market Share, By Test Type (2018)
Figure 39: Middle East & Africa Treponema Pallidum Tests Market Share, By Service Provider (2018)
Figure 40: Middle East & Africa Treponema Pallidum Tests Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Middle East & Africa Treponema Pallidum Tests Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 42: Middle East & Africa Treponema Pallidum Tests Market Attractiveness Analysis, By Country
Figure 43: Middle East & Africa Treponema Pallidum Tests Market Attractiveness Analysis, By Test Type
Figure 44: Middle East & Africa Treponema Pallidum Tests Market Attractiveness Analysis, By Service Provider
Figure 45: Global Treponema Pallidum Tests Market Share Analysis (%) By Region, 2018 & 2026
Figure 46: Global Treponema Pallidum Tests Market Y-o-Y Growth (%) By Region, 2018–2026
Figure 47: Global Treponema Pallidum Tests Market Attractiveness Analysis By Region, 2018–2026
Figure 48: Global Treponema Pallidum Tests Market Share Analysis (%) By Test Type, 2018 & 2026
Figure 49: Global Treponema Pallidum Tests Market Y-o-Y Growth (%) By Test Type, 2018–2026
Figure 50: Global Treponema Pallidum Tests Market Attractiveness Analysis By Test Type, 2018–2026
Figure 51: Global Treponema Pallidum Tests Market Share Analysis (%) By Service Provider, 2018 & 2026
Figure 52: Global Treponema Pallidum Tests Market Y-o-Y Growth (%) By Service Provider, 2018–2026
Figure 53: Global Treponema Pallidum Tests Market Attractiveness Analysis By Service Provider, 2018–2026
Figure 54: Global Treponema Pallidum Tests Market Value Analysis and & Y-o-Y Growth (%), 2015–2026
Figure 55: Global Treponema Pallidum Tests Market Absolute $ Opportunity, 2013–2026